TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Capital Expenditures (2020 - 2026)

Updated

TScan Therapeutics (TCRX) recorded Capital Expenditures of $41,000 in Q3 2026, down 97.1% from $1.43 million a year earlier and down 91.7% from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Capital Expenditures (2020 - 2026) Analysis & Trends

On a TTM basis, TScan Therapeutics' Capital Expenditures came in at $775,000 as of Sep 30, 2026, down 84.9% year-over-year; for FY2025, it was $4.41 million, up 15.2% from FY2024.

  • Annual Capital Expenditures has a five-year compound annual growth rate of 0.8% (FY2020 to FY2025).
  • Across earlier years, Capital Expenditures came in at $3.83 million in FY2024 (+21.6%), $3.15 million in FY2023 (-25.5%), $4.23 million in FY2022 (-57.5%) and $9.94 million in FY2021 (+134.6%).
  • The Q3 2026 figure is the lowest quarterly Capital Expenditures in data going back to Q3 2020.
  • On a year-over-year basis, Capital Expenditures has declined for four consecutive quarters, with an average decline of 9.5% over the last eight quarters.
  • Peak year-over-year performance for Capital Expenditures in the last five years was growth of 234.7% in Q3 2023, against a decline of 97.1% in Q3 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $493,000 (Q2 2026), $70,000 (Q1 2026) and $171,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -39,045.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 3.18 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 1.36 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 301.00 Mn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 1.04 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 237.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 TScan Therapeutics 18.87 Mn -434.83 Mn - 41,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 41,000.00
Jun 30, 2026 493,000.00
Mar 31, 2026 70,000.00
Dec 31, 2025 171,000.00
Sep 30, 2025 1.43 Mn
Jun 30, 2025 1.28 Mn
Mar 31, 2025 1.53 Mn
Dec 31, 2024 888,000.00
Sep 30, 2024 1.37 Mn
Jun 30, 2024 862,000.00
Mar 31, 2024 705,000.00
Dec 31, 2023 469,000.00
Sep 30, 2023 1.42 Mn
Jun 30, 2023 420,000.00
Mar 31, 2023 838,000.00
Dec 31, 2022 1.38 Mn
Sep 30, 2022 424,000.00
Jun 30, 2022 1.89 Mn
Mar 31, 2022 531,000.00
Dec 31, 2021 2.21 Mn
API Access

TScan Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TCRX&period=max&api_key=YOUR_API_KEY